Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Addict Behav Rep ; 15: 100424, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35541027

ABSTRACT

Introduction: Substance use in Zambia is stigmatized and treatment access is limited. Over 30,000 people are homeless in Lusaka, where one-quarter of homeless youth report use. Zambia's Ministry of Health recently developed policies targeting alcohol, suggesting Chainama, the only mental health hospital, offer treatment. Together, they endorsed training in the curriculum studied in this paper. We hypothesized training Zambian professionals would improve their perceptions of substance users and treatment. We then explored if treatment using the curriculum, as delivered to clients by training participants, would encourage client motivation to change, participation in groups, and reduce substance use frequency. Methods: Part 1: One-hundred professionals were trained in a curriculum-based, literacy-free intervention employing cognitive behavioral and rational emotive behavior therapy techniques to explore 12 Steps of addiction recovery through Zambian art forms. Pre/post questionnaires captured perspectives around substance users and treatment. Part 2: Trained organizations delivered the curriculum in their communities. Twenty-five organizations rated feasibility and benefit of the curriculum. Data for 200 clients recorded pre/post motivation to change, open-sharing/participation, and frequency of substance use. Results: While training significantly modified professionals' perspectives regarding the value of offering treatment, their views of substance users did not change. Clients endorsed increases in "motivation to change" and "participation/open-sharing." Frequency of alcohol, marijuana, inhalant, and cigarette use significantly decreased. Conclusion: Training in the curriculum helped address a public health need, playing a role in increased motivational variables and decreased substance use. Research addressing this study's limitations is encouraged. Video abstract: For a video summary of this paper, please visit https://youtu.be/uDZTVxtzF1Y.

2.
Int Rev Immunol ; 34(2): 154-87, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25901860

ABSTRACT

Cancer immunotherapy comprises different therapeutic strategies that exploit the use of distinct components of the immune system, with the common goal of specifically targeting and eradicating neoplastic cells. These varied approaches include the use of specific monoclonal antibodies, checkpoint inhibitors, cytokines, therapeutic cancer vaccines and cellular anticancer strategies such as activated dendritic cell (DC) vaccines, tumor-infiltrating lymphocytes (TILs) and, more recently, genetically engineered T cells. Each one of these approaches has demonstrated promise, but their generalized success has been hindered by the paucity of specific tumor targets resulting in suboptimal tumor responses and unpredictable toxicities. This review will concentrate on recent advances on the use of engineered T cells for adoptive cellular immunotherapy (ACI) in cancer.


Subject(s)
Immunotherapy, Adoptive , Neoplasms/therapy , Receptors, Antigen, T-Cell/metabolism , T-Lymphocytes/physiology , Animals , Genetic Engineering , Humans , Neoplasms/immunology , Receptors, Antigen, T-Cell/genetics , Recombinant Fusion Proteins/genetics , T-Lymphocytes/transplantation
3.
Ann Transl Med ; 2(9): 87, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25405162

ABSTRACT

Galectins are family of galactose-binding proteins known to play critical roles in inflammation and neoplastic progression. Galectins facilitate the growth and survival of neoplastic cells by regulating their cross-talk with the extracellular microenvironment and hampering anti-neoplastic immunity. Here, we review the role of galectins in the biology of hematological malignancies and their promise as potential therapeutic agents in these diseases.

4.
J Athl Train ; 36(3): 303-306, 2001 Sep.
Article in English | MEDLINE | ID: mdl-12937500

ABSTRACT

OBJECTIVE: To document neurocognitive and neurobehavioral consequences of 1 versus 2 concussions. DESIGN AND SETTING: Nonequivalent, pretest-posttest cohort design with multiple dependent measures. Participants were selected from a large sample of athletes who participated in a comprehensive, multiuniversity study of football-related concussion. SUBJECTS: College football players who sustained 1 and 2 grade 1 concussive injuries were matched for age, education, and duration of competitive football. MEASUREMENTS: Neuropsychological tests and symptoms checklists. RESULTS: Multivariate analysis of variance did not show a statistically significant difference in test performance between players with 1 or 2 concussions. Chi square analyses revealed that concussions significantly increased the number of symptom complaints, but symptoms returned to baseline by 10 days postinjury. The effects of 2 injuries did not appear to be significantly greater than that of a single injury. Differences in response to concussion were observed. CONCLUSIONS: Neurocognitive and neurobehavioral consequences of 2 concussions did not appear to be significantly different from those of 1 concussion, but methodologic issues place limitations on data interpretation. Additional studies are needed to clarify the neuropsychological consequences of multiple concussions.

SELECTION OF CITATIONS
SEARCH DETAIL
...